Publication | Open Access
Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I–type II study from the GINECO group
64
Citations
24
References
2017
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1